Big Idea Ventures announces cohort of 17 start-ups
Big Idea Ventures has revealed its latest accelerator cohort. Seventeen early-stage startups were selected for…
October 5, 2022 - 7 minutes
News and Trends
FDA fast tracks Immutep non-small cell lung cancer candidate
Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track…
October 5, 2022 - 3 minutes
News and Trends
Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract
Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract Intravacc has been awarded a…
October 5, 2022 - 3 minutes
News and Trends
OncoSec slashing staff numbers to prioritize pipeline
OncoSec Medical Incorporated is restructuring to prioritize development of its lead clinical candidate TAVO (TAVO-EP).…
October 5, 2022 - 2 minutes
What's New
MoreNew biotech company aims to bridge gap between stem cell research and athletic injuries
Andrews Medicine of Pensacola, Florida, and Celltex Therapeutics Corporation of Houston, Texas, are to form…
October 5, 2022 - 3 minutes
Transcenta monoclonal antibody gets FDA clearance
Transcenta Holding Limited says its TST004 humanized monoclonal antibody targeting MASP2, has received IND clearance…
October 5, 2022 - 2 minutes
CanSinoBIO to present latest data on inhaled COVID vaccine
CanSino Biologics Inc. will be presenting clinical trial data for the recombinant COVID-19 vaccine (adenovirus…
October 5, 2022 - 2 minutes
Araris Biotech closes $24M financing round for ADCs
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the…
October 5, 2022 - 2 minutes
TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies
TrialSpark has announced a new partnership with global pharma company Sanofi to explore novel methods…
October 4, 2022 - 2 minutes
ASPIRE set up to collaborate on amyloidosis
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research…
October 4, 2022 - 3 minutes
Aeglea BioTherapeutics updates homocystinuria program
Aeglea BioTherapeutics, Inc. says dosing in the third cohort of the phase 1/2 clinical trial…
October 4, 2022 - 3 minutes
Absolute Biotech launches as unified antibody company
Absolute Biotech has launched as a unified company to join antibody-centric brands from around the…
October 4, 2022 - 2 minutes
From Our Partners
View MoreHow digital solutions are transforming biomanufacturing
Sponsored
by Biognosys
Using the power of proteomics to predict immunotherapy responses in melanoma and beyond
Sponsored
by ACROBiosystems
How high quality raw materials help cell therapies successfully translate from bench to bedside
Sponsored
by LINK Medical
How clinical trials benefit from decentralized solutions: A Nordic case study
Download our industry reports
View all our reports
